Variable | Treatment | Total patients (n = 301) | Pearson’s Chi-Squared p-value | ||
---|---|---|---|---|---|
Corticosteroids (n = 95) | Corticosteroids AndColchicine (n = 145) | Without Corticosteroids (n = 61) | |||
Age | 55.9 (± 18) | 59.1 (± 16.5) | 53.7 (± 17.5) | 56.8 (± 17.3) | – |
Sex | |||||
Male | 61 (64.2%) | 75 (51.7%) | 42 (68.9%) | 178 (59.1%) | 0.04 |
Female | 34 (35.8%) | 70 (48.3%) | 19 (31.1%) | 123 (40.9%) | |
Comorbidities | 71 (74.7%) | 109 (75.2%) | 45 (73.8%) | 225 (74.8%) | 0.98 |
Cancer | 5 (5.3%) | 9 (6.2%) | 2 (3.3%) | 16 (5.3%) | 0.69 |
Hypothyroidism | 4 (4.2%) | 18 (12.4%) | 7 (11.5%) | 29 (9.6%) | 0.09 |
Heart disease | 1 (1%) | 5 (3.5%) | 1 (1.9%) | 7 (2.3%) | 0.45 |
Renal failure | 2 (2.1%) | 12 (8.3%) | 4 (6.6%) | 18 (5.9%) | 0.14 |
Dementia | 2 (2.1%) | 6 (4.1%) | 4 (6.6%) | 12 (3.9%) | 0.38 |
Obesity | 22 (23.2%) | 15 (10.3%) | 5 (8.2%) | 42 (13.9%) | 0.007 |
COPD | 12 (12.6%) | 15 (10.3%) | 3 (4.9%) | 30 (9.9%) | 0.29 |
Diabetes mellitus | 21 (22.1%) | 38 (26.2%) | 14 (22.9%) | 73 (24.3%) | 0.74 |
Hypertension | 44 (46.3%) | 67 (46.2%) | 26 (42.6%) | 137 (45.5%) | 0.88 |
Dyslipidemia | 4 (4.2%) | 19 (13.1%) | 4 (6.6%) | 27 (8.9%) | 0.05 |
Autoimmune disease | 3 (3.2%) | 1 (0.7%) | 3 (4.9%) | 7 (2.3%) | 0.15 |
Psychiatric disease | 1 (1.1%) | 5 (3.4%) | 1 (1.6%) | 7 (2.3%) | 0.45 |
Neurological disease | 6 (6.3%) | 1 (0.7%) | 4 (6.6%) | 11 (3.7%) | 0.03 |
Coronary disease | 5 (5.3%) | 11 (7.6%) | 2 (3.3%) | 18 (5.9%) | 0.46 |
Tobacco addiction | 11 (11.6%) | 14 (9.7%) | 9 (14.8%) | 34 (11.3%) | 0.57 |